FDA Approved: OGSIVEO — Original Application (SpringWorks Therapeutics, Inc.)

View source ↗

Summary

FDA approved OGSIVEO (nirogacestat) through an original NDA submitted by SpringWorks Therapeutics, Inc. for the treatment of desmoid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Desmoid Tumor
• Desmoid-type Fibromatosis

Drugs mentioned

• OGSIVEO (NIROGACESTAT)

Snippet

ORIG AP for OGSIVEO (NIROGACESTAT)